CLASS ACTION UPDATE for ASTR, CABA and ERIC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / April 7, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

ASTR Shareholders Click Here: https://www.zlk.com/pslra-1/astra-space-inc-f-k-a-holicity-inc-loss-submission-form?prid=25707&wire=1
CABA Shareholders Click Here: https://www.zlk.com/pslra-1/cabaletta-bio-inc-loss-submission-form?prid=25707&wire=1
ERIC Shareholders Click Here: https://www.zlk.com/pslra-1/telefonaktiebolaget-lm-ericsson-loss-submission-form?prid=25707&wire=1

* ADDITIONAL INFORMATION BELOW *

Astra Space Inc. f/k/a Holicity Inc. ASTR

ASTR Lawsuit on behalf of: investors who purchased February 2, 2021 - December 29, 2021
Lead Plaintiff Deadline : April 11, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/astra-space-inc-f-k-a-holicity-inc-loss-submission-form?prid=25707&wire=1

According to the filed complaint, during the class period, Astra Space Inc. f/k/a Holicity Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Astra cannot launch "anywhere"; (2) Astra significantly overstated its addressable market; (3) Astra overstated the effectiveness of its designs and reliability; (4) Astra significantly overstated its plans for diversification and its broadband constellation plan; and (5) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Cabaletta Bio, Inc. CABA

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Cabaletta common stock pursuant and/or traceable to documents issued in connection with the Company's initial public offering conducted on or about October 24, 2019; and/or (b) Cabaletta securities between October 24, 2019 and December 13, 2021, both dates inclusive.
Lead Plaintiff Deadline : April 29, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/cabaletta-bio-inc-loss-submission-form?prid=25707&wire=1

According to the filed complaint, (i) top-line data of the Phase 1 Clinical Trial indicated that Cabaletta's lead product candidate, DSG3-CAART, had, among other things, worsened certain participants' disease activity scores and necessitated additional systemic medication to improve disease activity after DSG3-CAART infusion; (ii) accordingly, DSG3-CAART was not as effective as the Company had represented to investors; (iii) therefore, the Company had overstated DSG3-CAART's clinical and/or commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Telefonaktiebolaget LM Ericsson ERIC

ERIC Lawsuit on behalf of: investors who purchased April 27, 2017 - February 25, 2022
Lead Plaintiff Deadline : May 2, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/telefonaktiebolaget-lm-ericsson-loss-submission-form?prid=25707&wire=1

According to the filed complaint, during the class period, Telefonaktiebolaget LM Ericsson made materially false and/or misleading statements and/or failed to disclose that: (i) Ericsson overstated the extent to which it had reformed its business practices to eliminate the use of bribes to secure business in foreign countries; (ii) Ericsson had paid bribes to the terrorist group the Islamic State in Iraq and Syria to gain access to certain transport routes in Iraq; (iii) accordingly, the Company's revenues derived from its operations in Iraq were, in at least substantial part, derived from unlawful conduct and thus unsustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE : Levi & Korsinsky, LLP